Objective: The primary aims of this trial were to evaluate the reproducibility of a portable handheld calorimeter (Medgem) in a clinical population, and to compare its measures with a calorimeter in typical use with these patients. Design: Cross-sectional clinical validation study. Setting: Outpatient Clinical Research Center. Subjects: A total of 24 stable home nutrition support patients. Interventions: In random order three measures of resting metabolic rate (RMR) were taken after a 4-h fast, 15 min rest and 2-h abstention from exercise. Two measures were taken with the same Medgem (MG) and one with the traditional calorimeter (Deltatrac). Reproducibility of MG measures and their comparability to a Deltatrac measure were assessed by Bland-Altman analysis, with 47250 kcal/day established a priori as a clinically unacceptable error. In addition, disagreement between the two types of measures was defined as greater than 10% difference. Results: The mean difference between two MG measures was À6.8 kcal/day, with limits of agreement between 233 and À247 kcal/day and clinically acceptable. The mean difference between the Deltatrac and mean of two MG measures was À162 kcal/day, with limits of agreement between 577 and À253 kcal/day and clinically unacceptable. In all, 80% of the repeated MG RMR measures agreed within 10%, and the mean MG reading agreed with the Deltatrac in 60% of cases. Conclusions: RMR obtained using the MG calorimeter has an acceptable degree of reproducibility, and is acceptable to patients. The MG measures, however, are frequently lower than traditional measures and require further validation prior to application to practice in this vulnerable patient group.
Introduction
Resting metabolic rate (RMR) represents 60-70% of caloric expenditure in individuals, the largest component of total energy expenditure (Feurer & Mullen, 1986; Shetty et al, 1996a; Matarese, 1997) . RMR can be calculated from the measurement of oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) using an indirect calorimeter (Feurer & Mullen, 1986; Shetty et al, 1996a; Matarese, 1997) . Accurate knowledge of RMR is important in the clinical setting for determining appropriate caloric needs to establish optimal nutrient prescription, particularly for patients with significant gastrointestinal malabsorption, where parenteral or enteral feedings may be required.
For the measurements of RMR to be useful, health care professionals need to have confidence in the accuracy of the indirect calorimetry measurement systems. Metabolic carts, such as the Deltatrac, have been shown to be reliable instruments for measuring RMR (Takala et al, 1989; Weissman et al, 1990; Tissot et al, 1995) . Despite the advantages of the Deltatrac, there are factors that deter its use (Nieman et al, 2003; St-Onge et al, 2003) .
Traditional calorimeters have been described as costly and cumbersome, require skilled operators, possible off-site equipment repairs and calibration difficulties (Nieman et al, 2003; St-Onge et al, 2003) . For these reasons, an inexpensive, easy-to-use, portable, and accurate device for measuring RMR in the clinical setting is desirable. The Medgem (MG) is a handheld device that measures VO 2 to estimate RMR (Nieman et al, 2003; St-Onge et al, 2003) .
The primary aims of this trial were to evaluate the reproducibility of the MG calorimeter in a clinical population, and to compare its readings with a calorimeter in typical use with these patients, the Deltatrac.
Methods
Inclusion criteria were all patients referred to a home nutrition support clinic for management of parenteral feedings or complicated gastrointestinal dysfunction. No diagnoses were excluded. The protocol was approved by the University of Pennsylvania Institutional Review Board and informed consent was obtained from all participants. All RMR tests were performed by the same operator.
Patients were fasted a minimum of 4 h, including abstention from caffeine and parenteral caloric infusions, prior to coming to the General Clinical Research Center at the University of Pennsylvania between 1100 and 1500 h for measurement of RMR. They were permitted to drink small quantities of water between RMR tests, if desired. Recent physical activity was questioned, but reported as uniformly limited due to their physical condition. Height and body weight were measured in light clothing with shoes removed, using a stadiometer and an electronic scale. Body mass index (BMI) was calculated as weight (kg)/height (m 2 ). Patients rested in a semirecumbent position in bed for 15 min prior to beginning measurements of RMR, and for 5 min between tests. All measurement rooms maintained ambient temperatures of 22-241C.
In random order, one measure with the Deltatrac (Sensormedics, Yorba Linda, CA, USA) and two measures with the same MG device (Healthetech, Golden, CO, USA) were taken. Patients were instructed to continue resting quietly but not to move or speak during the measurements.
The oxygen sensor of the Deltatrac calorimeter was tested with the ethanol burn test prior to and midway through the series of patient measurements, to verify optimal machine functioning. The Deltatrac calorimeter was moved to the General Clinical Research Center and was allowed to warm up for 30 min prior to calibration against a calibration gas of 96% oxygen and 4% carbon dioxide (Puritan Medical Products, Overland Park, KS, USA).
The canopy was placed over the patient's face, and its attached plastic sheet smoothed into contact with the bed at all points. The test was recorded for 20 min. The first 5 min were eliminated as acclimatization artefact and from the next 15 min a segment of five consecutive 1-min measures with r5% coefficient of variation (CV) in VO 2 and VCO 2 was accepted as a steady-state reading. If a steady-state reading could not be obtained, the test was considered a failure. If the respiratory quotient (RQ), the ratio of VCO 2 to VO 2 was 41.0 or o0.7, the reading was rejected and a second measure taken after recalibration of the Deltatrac. If the second measure also had an out of range RQ, the test was considered a failure. The Deltatrac measures both VO 2 and VCO2 to calculate RMR using the abbreviated Weir equation (De Weir, 1949) :
where VO 2 and VCO 2 are measured in L/d.
The MG protocol included use of a new disposable mouthpiece for each individual, and permitting the patient to test the mouth-feel of the mouthpiece prior to testing. The patient was instructed to place the plastic nose clip comfortably on the nose, and to breathe nasally to ensure that air leaks were not present. The calorimeter was autocalibrated during 5 s to set the airflow sensors. The MG sensors measure relative humidity, barometric pressure and temperature, in addition to the oxygen concentration in inspired and expired airflow. The volume of inspired and expired air was measured by an ultrasonic sensor. The measurement was conducted with the patient holding the calorimeter with arm resting against the chest. Readings typically require 5-10 min for completion, with data saved directly into a database. The MG eliminates the first 2 min as patient acclimatization to the instrument, and attempts to obtain a steady-state reading in the next 3-8 min, using a rolling boxcar methodology on reiterative sets of VO 2 in 30 breaths to determine the slope of the line of best fit. VCO 2 is not measured and an RQ of 0.85 is assumed. Steady state is declared and the test is terminated when the minimal slope criterion is achieved. When steady state is not achieved in 5 min, a mathematical average of the data during the last 8 min of testing is used as RMR. The CV for repeated testing with the MG, measured against a mechanical simulator is o1.5% and against Douglas bag gas collection o1% difference (Healthetech, personal communication). If adequate gas samples are not obtained, an error message is given and the test aborted. If an error message was obtained, the device was recalibrated and a second attempt to measure RMR was made. If the second attempt was also unsuccessful, the test was considered a failure. The modified Weir equation (De Weir, 1949 ) is used, as outlined below, to calculate RMR projected over 24 h:
Patients were also asked to rate their subjective preference of the mouthpiece and nose clip gas collection system with the MG vs the canopy system with the Deltatrac.
Statistical evaluation
Descriptive statistics (mean, standard deviation) were obtained for all variables using SPSS 12.0. (SPSS Inc, Chicago, IL, USA). MG reproducibility and agreement with Deltatrac RMR were assessed using Bland-Altman limits of agreement testing (Bland & Altman, 1986) . A difference in RMR between the two comparison groups greater than 7250 kcal was considered a priori to be clinically unacceptable, since an unintentional weight change of 1/2 pound per week would be expected if the reading were applied to caloric supply. Additionally, individual data were examined for the percentage difference between the two MG measures and between the mean MG and the Deltatrac measure. Measures within 10% of each other were considered acceptable, and the frequency and direction of outliers was described. To evaluate any interaction of order of RMR testing, repeated measures ANOVA was used, with pairwise measures using a Bonferroni adjustment for multiple comparisons.
Results

Patient characteristics
The characteristics of the patient group are presented in Table 1 . Eleven of the 24 subjects were male. The mean age was 46.8715.1 y, and BMI was 21.873.1 kg/m 2 . In all, 18 patients were currently dependent on intravenous nutrients, and all had been during the course of their recent clinical care.
Measurement acceptability
Three of the 24 subjects had Deltatrac readings where VO 2 and VCO 2 did not meet the 5% CV steady-state requirement (5.3, 7.7 and 10.1%). The mean CV of Deltatrac RMRs was 3.372.1% including these three unaccepted readings (2.671.1% with unaccepted readings excluded). One subject was not able to obtain a second MG measurement, due to receiving an error message after two efforts. The remaining data from these four subjects were included in the descriptive statistics, but the failed Deltatrac and MG readings considered as missing data for the Bland-Altman analysis. No Deltatrac measures were eliminated on the basis of out of range RQ.
MG reproducibility
The mean MG RMR and VO 2 measures (Table 2) were similar across both readings. Bland-Altman analysis comparing two MG RMRs (Figure 1 ) derived a mean difference of À6.8 kcal, with limits of agreement from þ 233 to À247 kcal. These limits were within the 250 kcal margin of acceptable error, suggesting adequate reproducibility with repeated MG measures.
MG individual data
When individual MG RMR readings were compared to each other, 80% were within the acceptable 10% difference. Of the 20% that were not considered accurate, the largest difference was a second MG reading that was 13% lower than the first.
Deltatrac vs MG comparison
The Deltatrac RMR was approximately 130 kcal greater than the MG readings ( Table 2 ). The Bland-Altman analysis comparing the Deltatrac RMR to the average of two MG readings (Figure 2 ) derived a mean bias of þ 162.3 kcal/day, with limits of agreement þ 577 to À253 kcal/day, and beyond the clinically acceptable 7250 kcal/day margin of error.
Individual data Deltatrac vs MG Only 60% of mean MG RMR measures were within 10% of Deltatrac RMR. Of the remaining 40%, in all cases the MG RMR was below the Deltatrac RMR (up to 18% below). 
Order of measurement
There was no significant linear order of measurement effect (F ¼ 0.556, df ¼ 1, P ¼ 0.465). Further, there were no significant pairwise differences between the mean measurement at one time and another. Hence, measurement order was not found to be a confounder.
Patient preference
Most patients preferred the Deltatrac canopy gas collection method, with the exception of one who expressed feeling claustrophobic in the canopy. Six subjects felt that the plastic from the canopy made them feel too warm by the end of the test, although they did not appear to be restless and no trend in higher readings at the end of the test was seen. One patient, who described experience as a scuba diver, preferred the mouthpiece and nose clip. No patient expressed that the mouthpiece and nose clip were unreasonably uncomfortable or that they could not tolerate this mode of gas collection for the time of the measurement.
Discussion
The subjects who participated in this trial are currently or have in the recent past been maintained on home parenteral nutrition (PN) secondary to limitations in their intestinal absorption of nutrients. Many suffer from short bowel syndrome as a result of Crohn's disease, mesenteric vascular disease or malignancy. Determining an accurate RMR is important in this population to combat the sequelae of nutrient malabsorption that may include unintended weight loss. Additionally, it is imperative to consider the risks of overfeeding or underfeeding in this population of patients if measurement of RMR is inexact but applied to intravenous caloric delivery. The risk of underfeeding in patients with PN support is iatrogenic malnutrition. Overfeeding can place individuals at risk for hyperglycemia, unintended weight gain, or PN-associated liver disease. These data, gleaned from a nutritionally fragile but clinically stable home nutrition support cohort, suggest that MG readings have adequate reproducibility and acceptability to patients, but different values from the traditional Deltatrac cart. This repeated measure reproducibility in MG RMR is similar to that reported in healthy populations (Weissman et al, 1990; Nieman et al, 2003) . Similar to this study's results, a recent comparison of MG accuracy to VMax229 RMR measures in 18 cancer patients found a mean bias of À10% with confidence limits of À42% to þ 12% (Reeves et al, 2005) .
Several possible reasons might explain why the Deltatrac RMR was usually higher than MG readings. One potential difference is the possibility that the RQ assumed by the MG of 0.85 is problematic. The mean RQ for the Deltatrac readings was in fact 0.7770.06 with a range of 0.7-0.86 (data not shown). However, the Deltatrac VO 2 , shown in Table 2 , was considerably higher than that measured by the MGs. Changing the RQ for the MG readings to that observed with the Deltatrac would only expand the observed difference in RMR. A second potential explanation for lower MG RMR readings is undetected air leaks around the mouthpiece or nose clip. Patients were carefully instructed in the correct use of the MG gas collection devices, were checked for air leaks through the nose and from the mouthpiece prior to RMR testing. It is still possible, however, that undetected air leaks may have developed during the 10 min of testing. A third factor to consider is a subject's anxiety with the gas collection device, here the nose clip/mouthpiece or canopy, since anxiety is known to increase RMR. All but one patient denied anxiety with both devices, suggesting that this was not a systematic error. Another variable to consider is the technological age of the oxygen sensors in the two calorimeters. The Deltatrac oxygen sensor appeared to perform acceptably in two ethanol burn tests and in gas calibrations prior to each measurement, however, the oxygen sensor was designed at least 15 y ago. By contrast to the Deltatrac, there is no available readout of the MG oxygen sensor function. Since only one patient was unable to obtain an acceptable MG reading and the reproducibility between repeated measures was tight, the oxygen sensors were likely functioning adequately. The MG oxygen sensors, however, were designed only a few years ago, have undergone repeated refinements in the recent past, and those used for this study were the latest available version. A further possibility is that the MGs were having difficulty obtaining a steady-state measurement in this patient group, as evidenced by a total of 28/40 MG measures where the time of measurement went to 9 or 10 min. If this was a problem, it was not severe enough to cause an error message for the reading and thus the measurement result was reported.
The optimal conditions for obtaining RMR measurement by indirect calorimetry should include consideration of recent physical activity, fasting and resting time and steady-state gas exchange conditions, as these factors are known to impact the accuracy of RMR. Physical activity was reportedly limited, due to the clinical condition of these patients, obviating the need for an exercise restriction prior to testing. A recent publication by the Institute of Medicine suggests that a range of 1.0-1.39 times the RMR will express total energy expenditure in sedentary individuals (Brooks et al, 2004) . In most of these patients, we may assume that their RMR is influenced very little by prior physical activity.
The hours of fasting needed to avoid measuring the thermic effect of food in addition to RMR is usually stated as 4 h (McClave & Snider, 1992) , so a 4-h fast was required for participation in this study. A study comparing the area under the curve of RMR above baseline measures over 6 h documented a total caloric increase from a 1200-kcal meal of 80-90 kcal (Kinabo & Durnin, 1990; Haugen et al, 2003) . The percentage of kcal burned during the fourth and fifth hour are 22 and 9%, respectively (Reed & Hill, 1996) , suggesting a limited increase above true RMR by measurement after a 4-h fast. Needless to say, these studies of thermic effect of feeding have been reported in healthy individuals, and not in patients who obtain significant caloric supply intravenously, thus bypassing the time required for digestion and absorption. It is likely that a shorter and not longer time of thermic effect of feeding would be applicable with these patients. Clearly, a 12-h fast would not be a reasonable requirement for a clinical population.
Actual data regarding optimal rest time are scant, although indirect calorimetry reviews have generally recommended 30 min rest (Feurer & Mullen, 1986; McClave & Snider, 1992) . A 7-min (Schols et al, 1992) , a 10-min (Igawa et al, 2002) , and a 25-min (Kashiwazaki et al, 1990) rest have been tested with no significant difference in RMR afterward. A protocol using a 30 min rest for the morning measure but a 15 min rest in the afternoon (Haugen et al, 2003) found o100 kcal difference in RMR, a difference that may have reflected the combined effects of rest time and length of fasting (12 vs 4 h). Thus the 15 min rest time employed in the current study was likely not a source of measurement error.
Finally, the definition of steady-state gas exchange acceptability employed in the Deltatrac measurements is rigorous and should have been adequate to predict RMR. In a recent evidence, analysis process by the American Dietetic Association expert panel (unpublished data), a 10% CV in VO 2 and VCO 2 was acceptable in healthy individuals who were measured over 10 min if the first 5 min was eliminated as acclimatization artefact. In this trial, we used the more stringent protocol of a 5% CV in five consecutive 1-min measures with a total measurement time of 20 min (Feurer & Mullen, 1986) . Two of our 'failed' Deltatrac readings would have been accepted by the more liberal 10 min with 10% CV criteria. Since a more rigorous method of determination of steady state with the Deltatrac measures was employed, error in these readings is unlikely.
The measurement protocol that will be employed in the future with this clinical group will include a 4-h fast, a 15-min rest, and a 10-min Deltatrac reading with discard of the first 5 min. If a 10% CV is attained, the measurement will be accepted. If not, the measure will be repeated after a 15-min rest. These protocol changes bring the time demand for Deltatrac readings in line with the MG protocol, where a 15-min rest with a 5 to 10-min RMR reading is standard.
Both the Deltatrac and MG calorimeters were easy to calibrate during this study, and the operation was straightforward. Both machines may require off-site equipment repairs. The Deltatrac is serviced regularly by the hospital clinical engineering staff and the MGs returned to Healthetech for calibration. Thus, there is little difference in their ease of use. Potential advantages of this new technology include the compact equipment needs (handheld unit þ laptop computer) vs the Deltatrac system that involves a rolling cart with 6.6 square feet of floor space and 3.4 feet vertical space. The combined acceptability of the MG readings with its portability and size make the MG appealing for use in clinical populations.
This study has several limitations that should be considered. First, repeated measures of Deltatrac RMR were not undertaken. The primary reason is that the reproducibility of this indirect calorimeter has been fully established by other investigators to be within 5% for repeated measures (Shetty et al, 1996b; Ventham & Reilly, 1999) . Secondly, the protocol employed with this investigation required a 20-min period of measurement to obtain a steady-state reading, a factor that would have provided greater patient burden with repeated tests. Thirdly, our goal was to compare the new handheld technology to an old standard, and thus repeated measures of the handheld instrument were needed but the established standard of less interest. A second limitation is the small size of the patient group who were measured. Clearly, it would be stronger to measure more patients. The clinical practice from which these patients were drawn is comprised of 50 patients, approximately 35% of whom are dependent on PN for a very short time, 25% have terminal cancer and are too ill to come for study, and the others were included if willing to participate. These patients are representative of an ethnically, racially mixed group of long-term nutrition care patients typically managed in the Eastern US.
To our knowledge, this is the first report of the comparability of MG to Deltatrac measures of RMR in such a nutritionally fragile clinical population. Although results of this trial reveal that measurements taken by the MG calorimeter are replicable and clinically acceptable, RMR measured by the MG was often lower than RMR obtained from the Deltatrac. Further research is needed before the MG can be used to replace the Deltatrac in a clinical population.
